RevatisAM was founded in 2016 in collaboration with Texas A&M University and its growth is underpinned by its innovative and patented technology to obtain pluripotent adult Mesenchymal Stem Cells from a minimally invasive muscle micro-biopsy. The company’s fields of activity cover R&D, veterinary medicine and human medicine. For more information, do not hesitate to contact us and visit the website of the parent company.
Board of Directors
Dr. S. McKenzie